TTDC update

Tennessee Technology Development Corporation (TTDC) may eventually need to look for private funding for its operations. Update here.

Stover exits TTDC

James Stover (left), after 3 years at COO at Tenn. Technology Development Corporation, is leaving for a new molecular-biology startup, backed by TriStar and Limestone TNInvestcos. Read about it here.

Hagerty TTDC Chair

The board of directors under Chairman Bill Evans, PharmD, this afternoon elected Haslam ECD Commissioner Bill Hagerty to serve through June 30, 2012, as chairman of TTDC. The story updated here.

TTDC at speed

Yesterday's announcement of $400K in grants for eight promising Tennessee ventures in development may signal Tennessee Technology Development Corporation is back at-speed. The VNC story's here.

TN Bio exec resigns, Venture-Tech Calendar updated

She had quietly served as chairperson since earlier this summer, now Leslie Wisner-Lynch has bid adieu to Tennessee Biotechnology Association... Also, VNC released its updated Venture-Tech Calendar. Both items are here.

Execs: TN biotech has earned 'right to exist' in niches

Memphis Daily News reports that Memphis BioWorks Foundation chief Steve Bares and Leslie Wisner-Lynch (at left) make the case that, while Tennessee is behind the curve in some bio sectors, we have strengths in others, such as med devices and biologics. The need to strengthen further Tennessee's ecosystem and infrastructure comes into play. Middle Tennessee-based Wisner-Lynch is the co-founder of BioTN LLC (a K-12 science-math initiative), a leader of the Tennessee Biotechnology Association, a member of the board of Tennessee Technology Development Corporation, and co-founder and formerly an executive with Biomimetic Therapeutics. The MDN's story is here.

Lynch updates on BioMimetic Therapeutics

The wheels of the gods grind slowly in the world of orthobiologics. So, The City Paper-NashvillePost update on Sam Lynch's Biomimetic Therapeutics is a timely review of recent developments within arguably mid-TN's most prominent Bio company. Here's our earlier story on the company, as well as our piece on Leslie Wisner-Lynch (at left) and the region's struggling biotech sector.